227 related articles for article (PubMed ID: 14631126)
1. Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.
Hwang WJ; Yao WJ; Wey SP; Ting G
Eur Neurol; 2004; 51(1):26-9. PubMed ID: 14631126
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
3. L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings.
Evans AH; Costa DC; Gacinovic S; Katzenschlager R; O'sullivan JD; Heales S; Lee P; Lees AJ
Mov Disord; 2004 Oct; 19(10):1232-6. PubMed ID: 15390012
[TBL] [Abstract][Full Text] [Related]
4. Normal dopamine transporter binding in dopa responsive dystonia.
Huang CC; Yen TC; Weng YH; Lu CS
J Neurol; 2002 Aug; 249(8):1016-20. PubMed ID: 12195447
[TBL] [Abstract][Full Text] [Related]
5. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
Yang YK; Yu L; Yeh TL; Chiu NT; Chen PS; Lee IH;
Am J Psychiatry; 2004 Aug; 161(8):1496-8. PubMed ID: 15285982
[TBL] [Abstract][Full Text] [Related]
6. Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys.
Ma KH; Huang WS; Chen CH; Lin SZ; Wey SP; Ting G; Wang SD; Liu HW; Liu JC
Nucl Med Biol; 2002 Jul; 29(5):561-7. PubMed ID: 12088726
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous 99mTc and 123I dual-isotope brain striatal phantom single photon emission computed tomography: validation of 99mTc-TRODAT-1 and 123I-IBZM simultaneous dopamine system brain imaging.
Kao PF; Wey SP; Yang AS
Kaohsiung J Med Sci; 2009 Nov; 25(11):601-7. PubMed ID: 19858039
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
Dresel SH; Kung MP; Huang XF; Plössl K; Hou C; Meegalla SK; Patselas G; Mu M; Saffer JR; Kung HF
J Nucl Med; 1999 Apr; 40(4):660-6. PubMed ID: 10210226
[TBL] [Abstract][Full Text] [Related]
9. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
Brunswick DJ; Amsterdam JD; Mozley PD; Newberg A
Am J Psychiatry; 2003 Oct; 160(10):1836-41. PubMed ID: 14514499
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
Hwang WJ; Yao WJ; Wey SP; Ting G
J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
[TBL] [Abstract][Full Text] [Related]
11. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
Kanyó B; Argyelán M; Dibó G; Szakonyi Z; Vécsei L; Fülöp F; Láncz A; Forgács P; Pávics L
Ideggyogy Sz; 2003 Jul; 56(7-8):231-40. PubMed ID: 12971118
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
[TBL] [Abstract][Full Text] [Related]
13. [99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome.
Hwang WJ; Yao WJ; Fu YK; Yang AS
Psychiatry Res; 2008 Feb; 162(2):159-66. PubMed ID: 18248965
[TBL] [Abstract][Full Text] [Related]
14. Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome.
Hesse S; Oehlwein C; Barthel H; Schwarz J; Polster D; Wagner A; Sabri O
J Neural Transm (Vienna); 2006 Sep; 113(9):1177-90. PubMed ID: 16463120
[TBL] [Abstract][Full Text] [Related]
15. SPG7 with parkinsonism responsive to levodopa and dopaminergic deficit.
Pedroso JL; Vale TC; Bueno FL; Marussi VHR; Amaral LLFD; França MC; Barsottini OG
Parkinsonism Relat Disord; 2018 Feb; 47():88-90. PubMed ID: 29246844
[TBL] [Abstract][Full Text] [Related]
16. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
[TBL] [Abstract][Full Text] [Related]
17. 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia.
Berding G; Gratz KF; Kolbe H; Meyer GJ; Dengler R; Knoop BO; Hundeshagen H
Nuklearmedizin; 1994 Oct; 33(5):194-9. PubMed ID: 7997377
[TBL] [Abstract][Full Text] [Related]
18. [123I]beta-CIT single-photon emission tomography in DOPA-responsive dystonia.
Naumann M; Pirker W; Reiners K; Lange K; Becker G; Brücke T
Mov Disord; 1997 May; 12(3):448-51. PubMed ID: 9159746
[TBL] [Abstract][Full Text] [Related]
19. SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.
Hwang WJ; Yao WJ
J Neuroimaging; 2013 Apr; 23(2):192-6. PubMed ID: 22211920
[TBL] [Abstract][Full Text] [Related]
20. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.
Swanson RL; Newberg AB; Acton PD; Siderowf A; Wintering N; Alavi A; Mozley PD; Plossl K; Udeshi M; Hurtig H
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
